MENU
HQL
ETF ticker: NYSE
PRICE
CHANGE
NET ASSETS

HQL stock forecast, quote, news & analysis

abrdn Life Sciences Investors operates as a non-diversified closed-end management investment company... Show more

HQL
Daily Signal:
Gain/Loss:
A.I.Advisor
published price charts
Interact to see
Advertisement
A.I.Advisor
a Summary for HQL with price predictions
Aug 18, 2026

HQL's MACD Histogram crosses above signal line

The Moving Average Convergence Divergence (MACD) for HQL turned positive on August 07, 2026. Looking at past instances where HQL's MACD turned positive, the stock continued to rise in of 48 cases over the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on August 05, 2026. You may want to consider a long position or call options on HQL as a result. In of 85 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where HQL advanced for three days, in of 318 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The RSI Indicator demonstrates that the ticker has stayed in the overbought zone for 7 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 8 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where HQL declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

HQL broke above its upper Bollinger Band on August 06, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for HQL entered a downward trend on August 12, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

A.I.Advisor
published Highlights

Industry description

abrdn Life Sciences Investors operates as a non-diversified closed-end management investment company. Its investment objective is to seek long-term capital appreciation by investing mainly in securities of life sciences companies. It invests in securities of public and private companies that are believed by the Fund’s Investment Adviser to have the potential for above-average growth.

Volume

The average weekly volume growth across all stocks in the abrdn Life Sciences Investors ETF was -9%. For the same stocks of the ETF, the average monthly volume growth was -4% and the average quarterly volume growth was -57%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 51
P/E Growth Rating: 35
Price Growth Rating: 31
SMR Rating: 49
Profit Risk Rating: 63
Seasonality Score: -32 (-100 ... +100)
View a ticker or compare two or three
HQL
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Category Unknown

Profile
Details
Category
Health
Address
2 Liberty Square9th FloorBoston
Phone
N/A
Web
https://www.teklacap.com/funds/hql/fund/fund-information/